We therefore proposed that the anti-metastatic activity of BMP4 could be mediated by SMAD4-dependent canonical signalling, and upon the loss of functional SMAD4, BMP4 could promote cancer progression through non-canonical signalling pathways (Fig. 1a). The gene discussed is SMAD4; the disease is cancer.